Syngene International to raise Rs 550 crore via IPO

24 Jul 2015 Evaluate

Bengaluru-based biopharmaceutical company Syngene International is all set to raise Rs 550 crore through an initial public offer (IPO). The price band for each equity share has been set at Rs 240-250. The issue will open on July 27 and close on July 29. This IPO is an offer for sale, meaning the money raised goes to the selling shareholders, not the company.

The equity shares will be listed on the NSE and the BSE. The book running lead managers to the issue are Axis Capital, Credit Suisse Securities (India), Jefferies India and Karvy Computershare.

Incorporated in 1993, Syngene International Ltd is a subsidiary of Biocon, a global biopharmaceutical enterprise focused on delivering affordable formulations and compounds. Syngene offer customized models as per their clients’ requirements. These range from a full-time equivalent (FTE) to a fee-for-service (FFS) model, or a combination thereof.

 

Syngene Internation. Share Price

686.60 12.45 (1.85%)
18-Mar-2025 09:49 View Price Chart
Peers
Company Name CMP
Syngene Internation. 686.60
Sagility India 41.29
AGS Transact Tech 11.46
Just Dial 831.50
Krystal Integrated 434.50
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...